The treatment landscape for locally advanced head and neck squamous cell carcinoma (LA HNSCC) has changed significantly.
Arrowhead Pharmaceuticals has received approval from the Australian TGA for Redemplo to treat familial chylomicronemia syndrome.
Senate Republicans say the dysfunction in the House is becoming a liability for the broader GOP brand ahead of this year’s midterm elections, warning that if …
One factor may shape how the body responds to extreme endurance exercise long before adulthood.